What is it about?
An interview with Dr. Luigi Di Biase, MD, PhD, FACC, FHRS about periprocedural anticoagulation strategies and the new research and developments being made in atrial fibrillation ablation.
Featured Image
Why is it important?
There are a variety of periprocedural anticoagulation strategies for atrial fibrillation (AF) ablation. Reducing the risks of bleeding and systemic thromboembolization are the main goals of anticoagulation management.
Perspectives
The management of patients taking oral anticoagulants in the periprocedural period poses a challenge because of these risks. Procedural-related stroke/transient ischemic attacks (TIAs) have reduced in frequency over time, but non-paroxysmal (persistent/permanent) patients who undergo ablation have a higher risk of stroke/TIA. However, studies show that whether using non-irrigated or open-irrigated catheters, AF ablation and periprocedural stroke remain a portentous association.
Angelina Wagner
Read the Original
This page is a summary of: INTERVIEW WITH LUIGI DI BIASE, MD, PhD, FACC, FHRS, Journal of Innovations in Cardiac Rhythm Management, March 2016, MediaSphere Medical LLC,
DOI: 10.19102/icrm.2016.070307.
You can read the full text:
Resources
Contributors
The following have contributed to this page
